OBJECTIVE: Polycystic kidney disease (PKD) is a common cause of end-stage renal failure and many of these patients suffer vascular dysfunction and hypertension. It remains unclear whether PKD is associated with abnormal microvascular structure. Thus, this study examined the renovascular structure in PKD. METHODS: PKD rats (PCK model) and controls were studied at 10 weeks of age, and mean arterial pressure (MAP), renal blood flow, and creatinine clearance were measured. Microvascular architecture and cyst number and volume were assessed using micro-computed tomography, and angiogenic pathways evaluated. RESULTS: Compared with controls, PKD animals had an increase in MAP (126.4 ± 4.0 vs. 126.2 ± 2.7 mmHg) and decreased clearance of creatinine (0.39 ± 0.09 vs. 0.30 ± 0.05 mL/min), associated with a decrease in microvascular density, both in the cortex (256 ± 22 vs. 136 ± 20 vessels per cm2) and medullar (114 ± 14 vs. 50 ± 9 vessels/cm2) and an increase in the average diameter of glomeruli (104.14 ± 2.94 vs. 125.76 ± 9.06 mm). PKD animals had increased fibrosis (2.2 ± 0.2 fold vs. control) and a decrease in the cortical expression in hypoxia inducible factor 1-α and vascular endothelial growth factor. CONCLUSIONS: PKD animals have impaired renal vascular architecture, which can have significant functional consequences. The PKD microvasculature could represent a therapeutic target to decrease the impact of this disease.
OBJECTIVE:Polycystic kidney disease (PKD) is a common cause of end-stage renal failure and many of these patients suffer vascular dysfunction and hypertension. It remains unclear whether PKD is associated with abnormal microvascular structure. Thus, this study examined the renovascular structure in PKD. METHODS:PKDrats (PCK model) and controls were studied at 10 weeks of age, and mean arterial pressure (MAP), renal blood flow, and creatinine clearance were measured. Microvascular architecture and cyst number and volume were assessed using micro-computed tomography, and angiogenic pathways evaluated. RESULTS: Compared with controls, PKD animals had an increase in MAP (126.4 ± 4.0 vs. 126.2 ± 2.7 mmHg) and decreased clearance of creatinine (0.39 ± 0.09 vs. 0.30 ± 0.05 mL/min), associated with a decrease in microvascular density, both in the cortex (256 ± 22 vs. 136 ± 20 vessels per cm2) and medullar (114 ± 14 vs. 50 ± 9 vessels/cm2) and an increase in the average diameter of glomeruli (104.14 ± 2.94 vs. 125.76 ± 9.06 mm). PKD animals had increased fibrosis (2.2 ± 0.2 fold vs. control) and a decrease in the cortical expression in hypoxia inducible factor 1-α and vascular endothelial growth factor. CONCLUSIONS:PKD animals have impaired renal vascular architecture, which can have significant functional consequences. The PKD microvasculature could represent a therapeutic target to decrease the impact of this disease.
Authors: Muna A Al-Nimri; Radko Komers; Terry T Oyama; Arohan R Subramanya; Jessie N Lindsley; Sharon Anderson Journal: Kidney Int Date: 2003-05 Impact factor: 10.612
Authors: Christopher J Ward; Marie C Hogan; Sandro Rossetti; Denise Walker; Tam Sneddon; Xiaofang Wang; Vicky Kubly; Julie M Cunningham; Robert Bacallao; Masahiko Ishibashi; Dawn S Milliner; Vicente E Torres; Peter C Harris Journal: Nat Genet Date: 2002-02-04 Impact factor: 38.330
Authors: Tatyana V Masyuk; Bing Q Huang; Anatoliy I Masyuk; Erik L Ritman; Vicente E Torres; Xiaofang Wang; Peter C Harris; Nicholas F Larusso Journal: Am J Pathol Date: 2004-11 Impact factor: 4.307
Authors: Xiang-Yang Zhu; Martin Rodriguez-Porcel; Michael D Bentley; Alejandro R Chade; Vincenzo Sica; Claudio Napoli; Noel Caplice; Erik L Ritman; Amir Lerman; Lilach O Lerman Journal: Circulation Date: 2004-03-29 Impact factor: 29.690
Authors: Qi Qian; Larry W Hunter; Ming Li; Miguel Marin-Padilla; Y S Prakash; Stefan Somlo; Peter C Harris; Vicente E Torres; Gary C Sieck Journal: Hum Mol Genet Date: 2003-08-01 Impact factor: 6.150
Authors: J Hughes; C J Ward; B Peral; R Aspinwall; K Clark; J L San Millán; V Gamble; P C Harris Journal: Nat Genet Date: 1995-06 Impact factor: 38.330
Authors: Karen M Peterson; Federico Franchi; Darrel L Loeffler; Peter J Psaltis; Peter C Harris; Lilach O Lerman; Amir Lerman; Martin Rodriguez-Porcel Journal: Am J Nephrol Date: 2013-08-30 Impact factor: 3.754
Authors: Federico Franchi; Karen M Peterson; Rende Xu; Brent Miller; Peter J Psaltis; Peter C Harris; Lilach O Lerman; Martin Rodriguez-Porcel Journal: Cell Transplant Date: 2014-10-06 Impact factor: 4.064
Authors: Federico Franchi; Karen M Peterson; Katherine Quandt; David Domnick; Timothy L Kline; Michaela Olthoff; Mojtaba Parvizi; Ezequiel J Tolosa; Vicente E Torres; Peter C Harris; Martin E Fernandez-Zapico; Martin G Rodriguez-Porcel Journal: Hypertension Date: 2020-10-05 Impact factor: 10.190
Authors: Nathan J Beaumont; Heather L Holmes; Adriana V Gregory; Marie E Edwards; Juan D Rojas; Ryan C Gessner; Paul A Dayton; Timothy L Kline; Michael F Romero; Tomasz J Czernuszewicz Journal: Kidney360 Date: 2020-10-29
Authors: Justin J Tse; P Joy Dunmore-Buyze; Maria Drangova; David W Holdsworth Journal: Contrast Media Mol Imaging Date: 2017-11-15 Impact factor: 3.161
Authors: Connor A Wathen; Nathan Foje; Tony van Avermaete; Bernadette Miramontes; Sarah E Chapaman; Todd A Sasser; Raghuraman Kannan; Steven Gerstler; W Matthew Leevy Journal: Sensors (Basel) Date: 2013-05-27 Impact factor: 3.576